Satoshi Muraoka
Papers
6
Total Citations
85
H-Index
4
About
Satoshi Muraoka is a pioneering urologic surgeon whose research is reshaping the landscape of prostate cancer treatment and robotic surgery. His work centers on optimizing surgical outcomes for prostate cancer patients, with a particular focus on the comparative effectiveness of robotic systems and the mitigation of post-operative complications. Muraoka has been instrumental in evaluating the novel hinotori™ surgical robot, demonstrating through propensity score-matched analyses that it achieves outcomes comparable to the established da Vinci® system in robot-assisted radical prostatectomy (RARP)—a finding with significant implications for surgical practice and healthcare economics. His prospective studies have also advanced the understanding of post-surgical recovery, notably identifying myosteatosis (fatty muscle degeneration) as a novel predictor of urinary incontinence after RARP, a contribution that has garnered 18 citations and offers a new target for pre-operative risk stratification. With over 85 total citations, Muraoka’s portfolio includes investigations into the natural history of pseudoaneurysms after partial nephrectomy and the prognostic impact of lymphatic invasion in high-risk prostate cancer. By integrating oncological outcomes with health-related quality of life, his work provides critical evidence for shared decision-making in prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6